News and Events

WHO guidelines for sun protection should be revised in light of new evidence

29 June 2018

Current guidelines from the World Health Organization that state sun protection is required only when the UV Index is 3 or greater are not evidence based and are somewhat simplistic. New evidence that suggests the UV Index is a continuous scale and more comprehensive sun protection is required as the UV Index increases should inform the revision of these guidelines for the future, according to this recent study.

Testing genomic variants helps predict melanoma risk

26 June 2018

Testing of genomic variants can identify people who are susceptible to melanoma despite not having a traditional phenotypic risk profile, according to this recent study which analysed data from Australia and the UK. 

Interferon Signaling Frequently Downregulated in Melanoma

25 June 2018

Melanoma responses to interferon-y are heterogeneous, frequently downregulated in immune checkpoint inhibitor-naïve melanoma and potentially predictive of response to immunotherapy, according to this recent study. 

Carcinogenic risk from UV nail lamps low

22 June 2018

Carcinogenic risk from UV nail lamps is low, however broad spectrum sunscreen with SPF >30, or protective gloves before UV nail lamp exposure is recommended, according to this recent study. 

ANZMTG Melanoma Margins Trial: a phase III randomised control trial investigating 1cm vs 2cm wide excision margins for primary cutaneous melanoma

20 June 2018

This feasibility study undertaken by the Australia and New Zealand Melanoma Trials Group (ANZMTG) was a phase III randomised control trial investigating 1cm vs 2cm wide excision margins for primary cutaneous melanoma. 

Results demonstrate the feasibility of a large international randomised control trial to provide a definitive answer to the optimal excision margin for patients with intermediate to high-risk primary cutaneous melanoma. Results also showed the rate of reconstruction is significantly increased when a wider margin is employed, which is consistent with previous randomised control trials.